Real-World Effectiveness of Insulin Glargine 300 Initiation in Switzerland
Robert Thomann,1 Stefan Zechmann,2 Nicola Alexander-David3,†, François R Jornayvaz4 1Bürgerspital Solothurn, Solothurn, Switzerland; 2Institute of Primary Care, University of Zurich, Zurich, Switzerland; 3Private Practice, Bellinzona, Switzerland; 4Hôpitaux U...
Saved in:
| Main Authors: | Thomann R, Zechmann S, Alexander-David N, Jornayvaz FR |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
Dove Medical Press
2020
|
| Subjects: | |
| Online Access: | https://doaj.org/article/a5a0f4f0a7b346c38eb61152ac5c83cc |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
rDNA insulin glargine U300 – a critical appraisal
by: Wang F, et al.
Published: (2016) -
Insulin glargine 300 U/mL for basal insulin therapy in type 1 and type 2 diabetes mellitus
by: Lau IT, et al.
Published: (2017) -
Effect of Adding Insulin Glargine on Glycemic Control in Critically Ill Patients Admitted to Intensive Care Units: A Prospective Randomized Controlled Study
by: Nader ND, et al.
Published: (2020) -
Association of Insulin Glargine Treatment with Bone Mineral Density in Patients with Type 2 Diabetes Mellitus
by: Liu D, et al.
Published: (2021) -
On the safety of insulin Glargine
by: Ivan Ivanovich Dedov, et al.
Published: (2009)